6,7-Dimethoxyquinolin-4-ol

We are 6,7-Dimethoxyquinolin-4-ol CAS:13425-93-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:6,7-Dimethoxyquinolin-4-ol
CAS.NO:13425-93-9
Synonyms:4-Hydroxy-6,7-dimethoxyqunioline
Molecular Formula:C11H11NO3
Molecular Weight:205.21000
 
Physical and Chemical Properties:
Density:1.206
Melting point:30ºC
Boiling point:355.3ºC
Flash point:168.7ºC
 
Specification:
Appearance:Yellow to off-white crystalline powder
Purity(HPLC):≥98.0%
Loss on drying:≤1.0%
Residue on ignition :≤0.5%
Any single impurity:≤0.5%
Total impurities:≤1.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Tivozanib
 
Note:The product under valid patents will not be offered to the countries covered by patents.

6,7-Dimethoxyquinolin-4-ol


Related News: This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.3663-44-3 At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.40665-68-7 Complete the research and development of APIs and intermediates, design new patented process routes, and explore new crystal forms.Hexamethyldisilane CAS:1450-14-2 The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).In addition, although the API and intermediate industries are capital-intensive and technology-intensive industries, new competitors are still joining.

Related Products
Product Name
4-Chloro-3-fluorophenylacetic acid View Details
Cetilistat View Details
(alphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride View Details
2-FLUORO-6-METHOXYBENZOIC ACID manufacturer 7-Fluoroindole manufacturer N-acetyl-4-oxo-L-proline manufacturer 2,3-Dichlorobenzotrifluoride manufacturer 2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)eth-2-ylamine manufacturer